Scarica l'app Stockscreener
75.87
0.75%
-0.57
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EW Giù?
Forum
Previsione
Frazionamento azionario
Edwards Lifesciences Corp Borsa (EW) Ultime notizie
Edwards Lifesciences completes key study on SAPIEN XT THV - MSN
Is Edwards Lifesciences Corporation stock a smart retirement pickPortfolio Value Summary & Free Accurate Trade Setup Notifications - mfd.ru
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day - The AI Journal
Edwards Lifesciences CFO at Citi medtech, life sciences access day Feb. 26 - Stock Titan
Rhumbline Advisers Acquires 15,792 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
How Investors Are Reacting To Edwards Lifesciences (EW) 2026 Guidance After Profit Squeeze In 2025 - Yahoo Finance
Halper Sadeh LLC Encourages Edwards Lifesciences - GlobeNewswire
Edwards Lifesciences Corporation $EW Shares Bought by Oppenheimer Asset Management Inc. - MarketBeat
Wells Fargo Raises Price Target for Edwards Lifesciences (EW) | - GuruFocus
Edwards Lifesciences Leans Into Growth After Strong Quarter - TipRanks
Edwards Lifesciences (EW): Truist Securities Maintains Hold Rati - GuruFocus
Edwards Lifesciences (EW) Analyst Ratings Update: Price Target L - GuruFocus
Edwards Lifesciences (NYSE:EW) Advances Structural Heart Solutions - Kalkine Media
Edwards Lifesciences Corp (NYSE:EW) Issues Upbeat Guidance - FXDailyReport.Com
Rothschild & Co Redburn Adjusts Edwards Lifesciences PT to $94 From $93, Maintains Buy Rating - marketscreener.com
Edwards Lifesciences 2026 Growth Targets Achievable, RBC Says - marketscreener.com
Piper Sandler Raises Price Target for Edwards Lifesciences (EW) to $100 | EW Stock News - GuruFocus
Edwards focuses on earlier TAVR adoption - MedTech Dive
Stifel reiterates Buy rating on Edwards Lifesciences stock at $110 target - Investing.com
Wells Fargo Raises Price Target for Edwards Lifesciences (EW) | EW Stock News - GuruFocus
Truist Securities Adjusts Price Target on Edwards Lifesciences to $89 From $92, Maintains Hold Rating - marketscreener.com
Wells Fargo & Company Raises Edwards Lifesciences (NYSE:EW) Price Target to $100.00 - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Q4 2025 Earnings Call Transcript - Insider Monkey
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $100 From $96, Maintains Overweight Rating - marketscreener.com
Leerink Partners Adjusts Price Target on Edwards Lifesciences to $87 From $88, Maintains Market Perform Rating - marketscreener.com
Baird Adjusts Price Target on Edwards Lifesciences to $87 From $90, Maintains Neutral Rating - marketscreener.com
Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $95 From $108, Maintains Buy Rating - marketscreener.com
The Analyst Verdict: Edwards Lifesciences In The Eyes Of 21 Experts - Benzinga
BTIG Reiterates Buy Rating for Edwards Lifesciences (EW) | EW St - GuruFocus
Why The Narrative Around Edwards Lifesciences EW Is Shifting After 2026 Outlook And JenaValve Setback - Yahoo Finance
Edwards Lifesciences Corp (EW) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst Strategic Investments - GuruFocus
Edwards Lifesciences Q4 Earnings Call Highlights - Yahoo Finance
Edwards Lifesciences earnings missed by $0.04, revenue topped estimates - Investing.com
Edwards Lifesciences (EW) Earnings Transcript - The Globe and Mail
Edwards Lifesciences misses EPS estimate by $0.04, surpasses revenue prediction - massdevice.com
Edwards Lifesciences (NYSE:EW) Sees S&P 500 Trading Uptick, Guidance - Kalkine Media
Earnings call transcript: Edwards Lifesciences Q4 2025 misses EPS forecast By Investing.com - Investing.com Nigeria
Edwards Lifesciences (NYSE:EW) Updates Q1 2026 Earnings Guidance - MarketBeat
Earnings call transcript: Edwards Lifesciences Q4 2025 misses EPS forecast - Investing.com
Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
Edwards Lifesciences (NYSE:EW) Issues Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Edwards Lifesciences forecasts 2026 profit above estimates on heart devices strength - marketscreener.com
Edwards Lifesciences Q4 Earnings Decline, Revenue Rises; Q1 Guidance Set - marketscreener.com
Edwards Lifesciences shares rise 5% as strong guidance overshadows Q4 earnings miss - Investing.com
(EW) Edwards Lifesciences Corporation Expects Q1 Revenue Range $1.55B$1.63B - marketscreener.com
(EW) Edwards Lifesciences Corporation Expects Q1 Adjusted EPS Range $0.70$0.76 - marketscreener.com
Edwards Lifesciences Q4 Earnings Summary & Key Takeaways - Benzinga
Edwards Lifesciences earnings up next: Can TAVR momentum last? By Investing.com - Investing.com UK
Edwards Lifesciences earnings up next: Can TAVR momentum last? - Investing.com
Edwards Lifesciences is Now Oversold (EW) - Nasdaq
Insights Ahead: Edwards Lifesciences's Quarterly Earnings - Benzinga
Palmetto Grain Brokerage - Palmetto Grain Brokerage
What Are Wall Street Analysts' Target Price for Edwards Lifesciences Stock? - Yahoo Finance
Stock Analysis: Is Edwards Lifesciences Corporation a stock for growth or value investors2025 EndofYear Setup & High Accuracy Investment Signals - baoquankhu1.vn
Is Edwards Lifesciences (EW) Share Weakness Creating A Valuation Opportunity? - Yahoo Finance
Estimating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW) - Yahoo Finance
Edwards Lifesciences Corporation $EW Shares Sold by AE Wealth Management LLC - MarketBeat
Edwards Lifesciences Nears SAPIEN M3 Decision As Big Money Moves - simplywall.st
FTC Victory in Edwards Lifesciences Merger: 4 Key Takeaways for Life Sciences Deals - JD Supra
Edwards Lifesciences advances smart surgery monitoring with completed SMART TRENDS study - MSN
Ahead of Edwards Lifesciences (EW) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
Seal The Valve, But Not The Deal: Court Blocks Edwards Lifesciences' Pre Commercial Merger - marketscreener.com
Edwards Lifesciences' Q4 Earnings on Deck: Here's What to Expect - Yahoo Finance
2.15%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):